Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun:68:103425.
doi: 10.1016/j.ebiom.2021.103425. Epub 2021 Jun 13.

Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"

Soha Ghanian  1 , Carlos G Wambier  2
Affiliations
Comment

Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"

Soha Ghanian et al. EBioMedicine. 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None Declared

Comment in

Comment on

  • Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males.
    Baldassarri M, Picchiotti N, Fava F, Fallerini C, Benetti E, Daga S, Valentino F, Doddato G, Furini S, Giliberti A, Tita R, Amitrano S, Bruttini M, Croci S, Meloni I, Pinto AM, Iuso N, Gabbi C, Sciarra F, Venneri MA, Gori M, Sanarico M, Crawley FP, Pagotto U, Fanelli F, Mezzullo M, Dominguez-Garrido E, Planas-Serra L, Schlüter A, Colobran R, Soler-Palacin P, Lapunzina P, Tenorio J, Pujol A, Castagna MG, Marcelli M, Isidori AM, Renieri A, Frullanti E, Mari F; Spanish Covid HGE, GEN-COVID Multicenter Study. Baldassarri M, et al. EBioMedicine. 2021 Mar;65:103246. doi: 10.1016/j.ebiom.2021.103246. Epub 2021 Feb 26. EBioMedicine. 2021. PMID: 33647767 Free PMC article.

References

    1. Baldassarri M. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males. EBioMedicine. 2021 - PMC - PubMed
    1. McCoy J. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. J Eur Acad Dermatol. Venereol. 2021;35(1):e15–e17. - PMC - PubMed
    1. Tirabassi G, Cignarelli A, Perrini S. Influence of CAG repeat polymorphism on the targets of testosterone action. Int J Endocrinol. 2015:1–12. - PMC - PubMed
    1. Cadegiani FA, McCoy J, Gustavo Wambier C, Goren A. Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial –Biochemical) Cureus. 2021 doi: 10.7759/cureus.13047. - DOI - PMC - PubMed
    1. Cadegiani F, Lin EM, Goren A, Wambier CG. Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ Case Report. 2021;14(2) - PMC - PubMed